The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lanreotide depot/autogel (LAN) vs. placebo (PBO) for carcinoid syndrome (CS) in patients with neuroendocrine tumors (NETs): Subgroup analysis of the ELECT study.
 
Aaron Vinik
Consulting or Advisory Role - Isis Pharmaceuticals; Merck; Neurometrix; Pamlab; Pfizer
Speakers' Bureau - Merck; Pamlab
Research Funding - Daiichi Sankyo; Impeto Medical; Intarcia Therapeutics; Pfizer; Tercica; ViroMed
 
Edward M. Wolin
Consulting or Advisory Role - Celgene; Ipsen; Novartis; Pfizer
Research Funding - Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Helene Audry
Consulting or Advisory Role - Ipsen
 
Edda Gomez-Panzani
Employment - Ipsen
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Consulting or Advisory Role - Genentech
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Medivation (Inst); Newlink Genetics (Inst); Novartis (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); PRA International (Inst); Tercica (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche